Joining the dots between personalized and precision medicine | CoronaCures Webinar with Dr. Debojyoti Chakraborty
Joining the dots between personalized and precision medicine
By Dr. Debojyoti Chakraborty
Senior Scientist
CSIR-Institute of Genomics and Integrative Biology (IGIB)
New Delhi, India
- Genome editing: moving towards translational outcomes
- Leveraging CRISPR for diagnosis and prevention
- The story of FELUDA for COVID-19 detection
Time: July 4, 2020, 07:00 PM IST
About the Speaker
Dr. Debojyoti Chakraborty is a senior scientist at CSIR-Institute of Genomics and Integrative Biology (IGIB) and heads an RNA Biology group. His lab is working on the development of efficient and specific tools for therapeutic genome editing, the systematic dissection of factors governing embryonic stem cell fate, and the use of cerebral organoids to address developmental questions such as influence of DNA topology on transcription. Using a combination of rational design of CRISPR Cas9 components and characterization of novel Cas9 orthologs, they have identified methods to increase the efficiency and specificity of this genome editing system. He is one of the inventors of ‘FELUDA‘- the first CRISPR based diagnostic kit (India’s first COVID-19 paper strip test).
For the meeting details please register here
